4
Changes in Ownership
MAIA Biotechnology, Inc. Filed Acc 0001127602-23-017884
Options or other derivatives
- Chief Executive Officer acquired 123,760 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Vitoc Vlad · Chief Executive Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-05-31 | Grant or award : show line 1 in the form Stock Options | +123,760 | 123,760 | D |
Loading xslF345X04/form4.xml…